Normethadone

Identification

Summary

Normethadone is an opioid antitussive used to treat a cough associated with inflamed mucosa.

Brand Names
Cophylac
Generic Name
Normethadone
DrugBank Accession Number
DB11609
Background

Normethadone is used as an opioid antitussive in combination with Oxilofrine. It is marketed in Canada by Valeant under the tradename Cophylac.

Type
Small Molecule
Groups
Approved, Illicit
Structure
Weight
Average: 295.426
Monoisotopic: 295.193614429
Chemical Formula
C20H25NO
Synonyms
  • 6-dimethylamino-4,4-diphenyl-3-hexanone
  • Desmethylmethadone
  • Isomethadone I
  • Normethadone
External IDs
  • Hoechst 10582
  • IDS-NN-007
  • J5.915C
  • NSC-19598

Pharmacology

Indication

For use in the treatment of cough when other less potent treatments have failed Label.

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

Normethadone is an opioid which suppresses coughing by central and peripheral mechanisms Label 1.

Mechanism of action

Normethadone activates central opioid receptors in the medulla to supress the cough reflex 1. It also likely activates peripheral opioid receptors to inhibit signalling by irritant receptors of the airway.

Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

The toxic effects of normethadone are similar to those of other opioids. It can produce respiratory depression, depression of central nervous system function, and constipation Label.

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
DrugInteraction
1,2-BenzodiazepineThe risk or severity of adverse effects can be increased when Normethadone is combined with 1,2-Benzodiazepine.
AcetazolamideThe risk or severity of CNS depression can be increased when Acetazolamide is combined with Normethadone.
AcetophenazineThe risk or severity of hypotension and CNS depression can be increased when Acetophenazine is combined with Normethadone.
AclidiniumThe risk or severity of adverse effects can be increased when Aclidinium is combined with Normethadone.
AgomelatineThe risk or severity of CNS depression can be increased when Agomelatine is combined with Normethadone.
Food Interactions
  • Avoid alcohol. Ingesting alcohol may cause additive CNS depressive effects.

Products

Drug product information from 10+ global regions
Our datasets provide approved product information including:
dosage, form, labeller, route of administration, and marketing period.
Access now
Access drug product information from over 10 global regions.
Access now
Product Ingredients
IngredientUNIICASInChI Key
Normethadone hydrochlorideOIV53II16G847-84-7GYWUCVKLUKFJLC-UHFFFAOYSA-N
Mixture Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
CophylacNormethadone hydrochloride (10 mg / mL) + Oxilofrine hydrochloride (20 mg / mL)Solution / dropsOralBausch Health, Canada Inc.1997-01-23Not applicableCanada flag
CophylacNormethadone hydrochloride (10 mg / mL) + Oxilofrine hydrochloride (20 mg / mL)Solution / dropsOralHoechst Canada Inc.1957-12-311996-09-09Canada flag
Cophylac DropsNormethadone hydrochloride (10 mg / mL) + Oxilofrine hydrochloride (20 mg / mL)Solution / dropsOralHoechst Roussel Canada Inc.1993-12-311999-08-11Canada flag

Categories

ATC Codes
R05DA06 — Normethadone
Drug Categories
Chemical TaxonomyProvided by Classyfire
Description
This compound belongs to the class of organic compounds known as diphenylmethanes. These are compounds containing a diphenylmethane moiety, which consists of a methane wherein two hydrogen atoms are replaced by two phenyl groups.
Kingdom
Organic compounds
Super Class
Benzenoids
Class
Benzene and substituted derivatives
Sub Class
Diphenylmethanes
Direct Parent
Diphenylmethanes
Alternative Parents
Aralkylamines / Gamma-amino ketones / Trialkylamines / Organopnictogen compounds / Organic oxides / Hydrocarbon derivatives
Substituents
Amine / Aralkylamine / Aromatic homomonocyclic compound / Carbonyl group / Diphenylmethane / Gamma-aminoketone / Hydrocarbon derivative / Ketone / Organic nitrogen compound / Organic oxide
Molecular Framework
Aromatic homomonocyclic compounds
External Descriptors
Not Available
Affected organisms
Not Available

Chemical Identifiers

UNII
KR2L2A68XL
CAS number
467-85-6
InChI Key
WCJFBSYALHQBSK-UHFFFAOYSA-N
InChI
InChI=1S/C20H25NO/c1-4-19(22)20(15-16-21(2)3,17-11-7-5-8-12-17)18-13-9-6-10-14-18/h5-14H,4,15-16H2,1-3H3
IUPAC Name
6-(dimethylamino)-4,4-diphenylhexan-3-one
SMILES
CCC(=O)C(CCN(C)C)(C1=CC=CC=C1)C1=CC=CC=C1

References

General References
  1. Adcock JJ: Peripheral opioid receptors and the cough reflex. Respir Med. 1991 Jan;85 Suppl A:43-6. [Article]
KEGG Drug
D07384
PubChem Compound
10090
PubChem Substance
347828004
ChemSpider
9687
RxNav
32009
ChEBI
135242
ChEMBL
CHEMBL346331
ZINC
ZINC000001847280
Wikipedia
Normethadone
FDA label
Download (480 KB)

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
Solution / dropsOral
Prices
Not Available
Patents
Not Available

Properties

State
Solid
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
Water Solubility0.00737 mg/mLALOGPS
logP3.84ALOGPS
logP4.59Chemaxon
logS-4.6ALOGPS
pKa (Strongest Acidic)18.8Chemaxon
pKa (Strongest Basic)8.83Chemaxon
Physiological Charge1Chemaxon
Hydrogen Acceptor Count2Chemaxon
Hydrogen Donor Count0Chemaxon
Polar Surface Area20.31 Å2Chemaxon
Rotatable Bond Count7Chemaxon
Refractivity92.85 m3·mol-1Chemaxon
Polarizability34.67 Å3Chemaxon
Number of Rings2Chemaxon
Bioavailability1Chemaxon
Rule of FiveYesChemaxon
Ghose FilterYesChemaxon
Veber's RuleYesChemaxon
MDDR-like RuleNoChemaxon
Predicted ADMET Features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSsplash10-0002-0090000000-85344c3f6b560efafe92
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSsplash10-0006-0290000000-4716ca19cc84da7e5e66
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSsplash10-05dj-6190000000-8c4238d9ac04019fa8d8
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSsplash10-014u-0930000000-a45801e5fe0364a9cb82
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSsplash10-0900-9720000000-1492f1d37e71ac973179
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSsplash10-0296-1920000000-7eb8d050f76ebf903502
Predicted 1H NMR Spectrum1D NMRNot Applicable
Predicted 13C NMR Spectrum1D NMRNot Applicable
Chromatographic Properties
Collision Cross Sections (CCS)
AdductCCS Value (Å2)Source typeSource
[M-H]-182.0333192
predicted
DarkChem Lite v0.1.0
[M-H]-171.60872
predicted
DeepCCS 1.0 (2019)
[M+H]+182.4812192
predicted
DarkChem Lite v0.1.0
[M+H]+173.96672
predicted
DeepCCS 1.0 (2019)
[M+Na]+182.3990192
predicted
DarkChem Lite v0.1.0
[M+Na]+180.05986
predicted
DeepCCS 1.0 (2019)

Drug created at June 24, 2016 22:29 / Updated at February 21, 2021 18:53